Financials in USD. Standardized financial statements.
A compact view of how Lisata Therapeutics, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $170,000 | $1.00M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $35.28M |
| Revenue Growth? | -83.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -100.0% | 0.0% |
| Cost of Revenue? | $146,000 | $0 | $0 | $0 | $0 | $63,000 | $65,000 | $225,000 | $372,000 | $450,266 |
| Gross Profit? | $24,000 | $1.00M | $0 | $0 | $0 | -$63,000 | -$65,000 | -$225,000 | -$372,000 | $4.15M |
| Gross Margin? | +14.1% | +100.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | +11.8% |
| Operating Expenses? | $18.23M | $23.41M | $25.71M | $57.60M | $29.05M | $19.14M | $20.09M | $16.99M | $27.59M | $35.48M |
| Operating Income? | -$18.21M | -$22.41M | -$25.71M | -$57.60M | -$29.05M | -$19.14M | -$20.09M | -$16.99M | -$27.59M | -$31.34M |
| EBITDA? | -$18.06M | -$22.23M | -$25.52M | -$57.53M | -$29.00M | -$19.08M | -$20.03M | -$16.76M | -$27.22M | -$29.03M |
| Income Before Tax | -$17.55M | -$20.78M | -$23.17M | -$56.70M | -$28.97M | -$19.01M | -$19.35M | -$16.17M | -$27.70M | -$31.26M |
| Income Tax Expense | -$962,000 | -$798,000 | -$2.33M | -$2.48M | -$1.51M | -$10.87M | $0 | -$1,000 | -$11.53M | $138,038 |
| Net Income? | -$16.59M | -$19.98M | -$20.84M | -$54.23M | -$27.47M | -$8.15M | -$20.10M | -$16.17M | $22.98M | -$32.66M |
| EPS? | $-1.91 | $-2.40 | $-2.58 | $-10.47 | $-7.45 | $-7.91 | $-29.20 | $-25.03 | $38.43 | $-74.81 |
| Diluted EPS? | $-1.91 | $-2.40 | $-2.58 | $-10.47 | $-7.45 | $-7.91 | $-29.20 | $-25.03 | $38.43 | $-74.81 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality